The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Rice Bran Oil and γ‐Oryzanol in the Treatment of Hyperlipoproteinaemias and Other Conditions
Abstract
Diet is the first (and sometimes the only) therapeutic approach to hyperlipoproteinaemias. Rice bran oil and its main components (unsaturated fatty acids, triterpene alcohols, phytosterols, tocotrienols, α‐tocopherol) have demonstrated an ability to improve the plasma lipid pattern of rodents, rabbits, non‐human primates and humans, reducing total plasma cholesterol and triglyceride concentration and increasing the high density lipoprotein cholesterol level. Other potential properties of rice bran oil and γ‐oryzanol, studied both in vitro and in animal models, include modulation of pituitary secretion, inhibition of gastric acid secretion, antioxidant action and inhibition of platelet aggregation. This paper reviews the available data on the pharmacology and toxicology of rice bran oil and its main components with particular attention to those studies relating to plasma lipid altering effects. Copyright © 2001 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Roles of PPARs in health and disease
Kersten, S., Desvergne, B., & Wahli, W. (2000) · Nature · doi:10.1038/35013000 · Cited by 1,956
Cited by
New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre?
Fardet, A. (2010) · Nutrition Research Reviews · doi:10.1017/s0954422410000041 · Cited by 1,030
Goufo, P., & Trindade, H. (2014) · Food Science & Nutrition · doi:10.1002/fsn3.86 · Cited by 669
Rice Bran: A Novel Functional Ingredient
Sharif, M. K., Butt, M. S., Anjum, F. M., & Khan, S. H. (2014) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.608586 · Cited by 440
Cicero, A. F. G., Colletti, A., Bajraktari, G., Descamps, O., Djuric, D. M., Ezhov, M., Fras, Z., Katsiki, N., Langlois, M., Latkovskis, G., et al. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nux047 · Cited by 295
Self-citationCicero, A. F. G., Colletti, A., Bajraktari, G., Descamps, O., Djuric, D. M., Ezhov, M., Fras, Z., Katsiki, N., Langlois, M., Latkovskis, G., et al. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.69326 · Cited by 281
Self-citationPhytochemicals and Antioxidant Capacities in Rice Brans of Different Color
Min, B., McClung, A. M., & Chen, M. (2011) · Journal of Food Science · doi:10.1111/j.1750-3841.2010.01929.x · Cited by 258
Rice bran nutraceutics: A comprehensive review
Sohail, M., Rakha, A., Butt, M. S., Iqbal, M. J., & Rashid, S. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1164120 · Cited by 256
Introduction to cereal processing and by-products
Papageorgiou, M., & Skendi, A. (2018) · Sustainable Recovery and Reutilization of Cereal Processing By-Products · doi:10.1016/b978-0-08-102162-0.00001-0 · Cited by 95
Cicero, A. F. G., & Colletti, A. (2016) · Phytomedicine · doi:10.1016/j.phymed.2015.10.011 · Cited by 70
Self-citation
Metadata
- Authors
- Cicero, A. F. G., & Gaddi, A.
- Venue
- Phytotherapy Research
- Publisher
- Wiley
- Published
- 2001-06
- Volume
- 15
- Issue
- 4
- Pages
- 277-289
- ISSN
- 0951-418X (ISSN-L)
- 1099-1573
- OpenAlex
- W2046846151
- Cited by
- 248
- References
- 1
- FWCI
- 4.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.